Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 5 studies | 20% ± 6% | |
GABAergic neuron | 4 studies | 38% ± 13% | |
glutamatergic neuron | 4 studies | 45% ± 16% | |
ciliated cell | 3 studies | 29% ± 2% | |
interneuron | 3 studies | 37% ± 18% | |
astrocyte | 3 studies | 27% ± 3% | |
oligodendrocyte | 3 studies | 19% ± 3% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 4 studies | 37% ± 10% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 744.09 | 1444 / 1445 | 100% | 11.85 | 183 / 183 |
lung | 100% | 793.62 | 577 / 578 | 100% | 9.97 | 1152 / 1155 |
brain | 100% | 1059.41 | 2640 / 2642 | 100% | 18.89 | 702 / 705 |
intestine | 100% | 788.25 | 966 / 966 | 99% | 11.01 | 522 / 527 |
stomach | 100% | 722.53 | 359 / 359 | 99% | 11.61 | 283 / 286 |
ovary | 100% | 1290.71 | 180 / 180 | 99% | 8.79 | 425 / 430 |
breast | 100% | 950.89 | 459 / 459 | 99% | 15.33 | 1103 / 1118 |
bladder | 100% | 876.33 | 21 / 21 | 97% | 9.94 | 491 / 504 |
prostate | 100% | 845.33 | 245 / 245 | 96% | 11.39 | 484 / 502 |
pancreas | 99% | 646.88 | 326 / 328 | 97% | 8.10 | 172 / 178 |
skin | 100% | 829.68 | 1804 / 1809 | 96% | 10.15 | 454 / 472 |
thymus | 100% | 1232.92 | 653 / 653 | 96% | 11.30 | 580 / 605 |
uterus | 100% | 1099.35 | 170 / 170 | 94% | 9.02 | 431 / 459 |
kidney | 100% | 745.37 | 89 / 89 | 93% | 6.84 | 842 / 901 |
adrenal gland | 100% | 1076.45 | 258 / 258 | 88% | 5.47 | 202 / 230 |
liver | 100% | 714.67 | 226 / 226 | 88% | 6.92 | 356 / 406 |
adipose | 100% | 855.09 | 1204 / 1204 | 0% | 0 | 0 / 0 |
spleen | 100% | 629.80 | 241 / 241 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 874.53 | 1334 / 1335 | 0% | 0 | 0 / 0 |
muscle | 100% | 754.91 | 800 / 803 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 93% | 8.00 | 42 / 45 |
heart | 93% | 527.67 | 801 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 90% | 7.08 | 26 / 29 |
peripheral blood | 69% | 467.36 | 645 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 69% | 3.48 | 55 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0006974 | Biological process | DNA damage response |
GO_0006468 | Biological process | protein phosphorylation |
GO_0051301 | Biological process | cell division |
GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
GO_0000278 | Biological process | mitotic cell cycle |
GO_2000772 | Biological process | regulation of cellular senescence |
GO_0097014 | Cellular component | ciliary plasm |
GO_0005829 | Cellular component | cytosol |
GO_0036064 | Cellular component | ciliary basal body |
GO_0035869 | Cellular component | ciliary transition zone |
GO_0035253 | Cellular component | ciliary rootlet |
GO_0005737 | Cellular component | cytoplasm |
GO_0030145 | Molecular function | manganese ion binding |
GO_0004674 | Molecular function | protein serine/threonine kinase activity |
GO_0106310 | Molecular function | protein serine kinase activity |
GO_0005524 | Molecular function | ATP binding |
Gene name | NEK4 |
Protein name | Serine/threonine-protein kinase Nek4 (EC 2.7.11.1) (Never in mitosis A-related kinase 4) (NimA-related protein kinase 4) (Serine/threonine-protein kinase 2) (Serine/threonine-protein kinase NRK2) non-specific serine/threonine protein kinase (EC 2.7.11.1) NIMA related kinase 4 |
Synonyms | STK2 |
Description | FUNCTION: Protein kinase that seems to act exclusively upon threonine residues (By similarity). Required for normal entry into proliferative arrest after a limited number of cell divisions, also called replicative senescence. Required for normal cell cycle arrest in response to double-stranded DNA damage. . |
Accessions | ENST00000487068.1 ENST00000496822.1 H7C5M0 ENST00000383721.8 [P51957-2] F8WAX1 ENST00000461689.5 ENST00000233027.10 [P51957-1] E7EX48 Q05DF6 A0A059V7J1 ENST00000535191.5 [P51957-3] P51957 |